Sofinnova Venture Partners X, L.P. - 28 Apr 2025 SCHEDULE 13D/A Report for Jade Biosciences, Inc. Common Stock, par value $0.0001 per share (JBIO)

Filing Manager
Sofinnova Venture Partners X, L.P.
Reporting Manager
Sofinnova Venture Partners X, L.P. ("SVP X")
Security
Jade Biosciences, Inc. Common Stock, par value $0.0001 per share
Symbol
JBIO
Disclosed Ownership
107,391 shares
Ownership
0.3%
Form type
SCHEDULE 13D/A
Filing time
05 Mar 2026, 06:04:35 UTC
Date of event
28 Apr 2025
SEC
View on sec.gov

Quoteable Key Fact

"Sofinnova Venture Partners X, L.P. disclosed 0.3% ownership in Jade Biosciences, Inc. Common Stock, par value $0.0001 per share (JBIO) on 28 Apr 2025."

Quick Takeaways

  • Sofinnova Venture Partners X, L.P. filed SCHEDULE 13D/A for Jade Biosciences, Inc. Common Stock, par value $0.0001 per share (JBIO).
  • Disclosed ownership: 0.3%.
  • Date of event: 28 Apr 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 05 Mar 2026, 06:04.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Sofinnova Venture Partners X, L.P. ("SVP X") 0.3% 107,391 107,391 0 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact 0001680200
Sofinnova Management X, L.P. ("SM X LP") 0.3% 107,391 107,391 0 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact
Sofinnova Management X-A, L.L.C. ("SM X LLC") 0.3% 107,391 107,391 0 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact
Dr. James I. Healy ("Healy") 0.3% 107,391 0 107,391 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact
Dr. Maha Katabi ("Katabi") 0.3% 107,391 0 107,391 /s/ Nathalie Auber Nathalie Auber/Attorney-in-Fact
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .